Welcome to our dedicated page for Graham Holdings SEC filings (Ticker: GHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Graham Holdings files hundreds of pages each year covering Kaplan鈥檚 global education enrollments, prime-time advertising rates at its TV stations, and even hospice care margins. Finding the right numbers across such diverse segments can be daunting.
Stock Titan solves that problem in seconds. Our AI reads every Graham Holdings annual report 10-K, quarterly earnings report 10-Q, 8-K material events, and proxy statement on executive compensation the moment they hit EDGAR. Plain-language summaries highlight where Kaplan tuition revenue is booked, how broadcast cash flow compares quarter over quarter, and which manufacturing units drove inventory swings.
- AG真人官方-time Graham Holdings insider trading Form 4 transactions with alerts when executives buy or sell shares
- Graham Holdings 8-K material events explained so you can react to acquisitions or segment divestitures quickly
- Side-by-side charts that turn footnotes into visual trends for education and media segments
Whether you search for 鈥淕raham Holdings SEC filings explained simply鈥� or 鈥渉ow to read the company鈥檚 proxy statement executive compensation,鈥� you鈥檒l land on the data you need. Our AI-powered analysis untangles revenue recognition rules, flags pension plan changes, and even tags related party car-wash deals so you don鈥檛 have to. Monitor Graham Holdings Form 4 insider transactions real-time, compare segment profits straight from the latest Graham Holdings quarterly earnings report 10-Q filing, and review the entire Graham Holdings annual report 10-K simplified鈥攁ll in one place. No more digging; just decision-ready insights.
Graham Holdings (GHC) Q2 2025 10-Q highlights. Revenue rose 2.6% YoY to $1.22 bn (services $668.6 m, goods $547.1 m). Operating costs were flat, lifting operating income 181% to $72.8 m and expanding margin to 6.0%. Net income attributable to shareholders swung to a $36.7 m profit (diluted EPS $8.35) from a $21.0 m loss in Q2 2024. Interest expense fell to $18.1 m from $91.4 m as accretion on the mandatorily redeemable non-controlling interest (NCI) abated.
For the first six months, revenue edged up 1.9% to $2.38 bn but net income dropped 41% to $60.6 m (EPS $13.81) because 2024 benefited from a $123.8 m gain on marketable securities versus a $32.3 m gain in 2025 and a $66.2 m settlement-related interest charge. Operating cash flow improved sharply to $140.8 m (vs $53.1 m).
Liquidity tightened: cash and equivalents declined 32% since December to $176.2 m, while current debt jumped to $502.1 m as the $399 m 5.75% notes move inside one year. Total debt stands at $816.4 m. The February $205 m cash/stock settlement cut the mandatorily redeemable NCI to $21.5 m, removing a large future obligation. Book value climbed to $4.35 bn. Management remains in covenant compliance.